Molecular Basis and Experimental Research Considerations of Leukocyte Transendothelial Migration
Molecular Basis and Experimental Research Considerations of Leukocyte Transendothelial Migration
Leukocyte transendothelial migration (TEM) is a key step in inflammatory recruitment, immune surveillance, and tissue repair. In essence, it is not a passive passage of leukocytes through the vascular wall, but a staged and regulated process jointly governed by leukocytes, endothelial cells, chemokines, adhesion molecules, and hemodynamic forces.
Keywords: leukocyte; transendothelial migration; inflammatory recruitment; selectins; integrins; endothelial cells; chemokines; vascular permeability
1 Process Positioning of Leukocyte Transendothelial Migration
1.1 A key step in inflammatory recruitment
The entry of leukocytes from the circulation into tissues generally proceeds through a continuous sequence of margination, rolling, activation, firm adhesion, crawling, and transendothelial migration. Transendothelial migration occurs after intravascular adhesion and represents the decisive step at which circulating immune cells truly enter the tissue microenvironment.
1.2 Biological significance
This process has significance at three levels:
(1) During infection and tissue injury, it directs neutrophils, monocytes, and lymphocytes to local lesions.
(2) Under homeostatic conditions, it supports immune surveillance and renewal of tissue-resident immune cell populations.
(3) Under pathological conditions, if migration is excessive or overly prolonged, it can amplify chronic inflammation, autoimmune injury, and vascular barrier disruption.
2 Endothelial Activation and the Permissive Environment for Migration
2.1 Differences between resting and activated endothelium
Under resting conditions, vascular endothelial cells are biased toward an anti-adhesive, low-permeability, and low-inflammatory phenotype. After stimulation by inflammatory factors such as TNF-α, IL-1β, LPS, or ischemia-reperfusion, endothelial cells upregulate E-selectin, P-selectin, ICAM-1, VCAM-1, and multiple chemokines, thereby shifting from a barrier-maintaining state to a recruitment-permissive state.
2.2 Chemokine presentation
The endothelial surface does not merely secrete chemokines into the environment. Instead, chemokines are immobilized on the luminal surface through glycosaminoglycans and related matrix components, forming a locally directional activation environment for leukocytes. Therefore, leukocytes do not sense a uniform concentration field, but rather a surface gradient shaped jointly by blood flow and endothelial presentation patterns.
3 Rolling and Initial Capture
3.1 Initial contact dominated by selectins
Within the bloodstream, leukocytes first rely on the selectin system to achieve deceleration and transient adhesion. Endothelial P-selectin and E-selectin bind glycosylated ligands such as PSGL-1 on leukocytes, enabling reversible adhesion and rolling behavior under shear stress.
3.2 Functional significance of rolling
Rolling is not an inefficient transitional step. Rather, it is a necessary preparatory phase for subsequent integrin activation. Only through deceleration and sustained contact with the endothelial surface do leukocytes gain the opportunity to interpret local chemokine signals and convert low-affinity integrins into high-affinity states.
4 Integrin Activation and Firm Adhesion
4.1 Inside-out activation
After chemokine receptors on leukocytes are activated, molecules such as Rap1, talin, and kindlin promote conformational changes in integrins, thereby increasing ligand affinity and receptor clustering. This process is known as inside-out signaling and represents the key transition from rolling to firm adhesion.
4.2 Major adhesion pairs
Firm leukocyte adhesion mainly depends on the following interaction pairs:
(1) LFA-1 (αLβ2) with ICAM-1/ICAM-2.
(2) Mac-1 (αMβ2) with ICAM-1 and additional ligands.
(3) VLA-4 (α4β1) with VCAM-1.
Different leukocyte subsets do not rely equally on these molecules. For example, neutrophils more commonly depend on the β2 integrin system, whereas monocytes and certain lymphocyte subsets are more sensitive to the VLA-4/VCAM-1 axis under specific inflammatory conditions.
5 Luminal Crawling and Selection of Transmigration Sites
5.1 Lateral crawling after adhesion
After firm adhesion, leukocytes usually do not cross the endothelium immediately. Instead, they undergo lateral crawling on the luminal endothelial surface. This process is often supported by interactions such as Mac-1/ICAM-1 and serves to identify sites more suitable for transmigration.
5.2 Determinants of transmigration site selection
Where leukocytes preferentially transmigrate depends on the following factors:
(1) The spatial distribution of adhesion and junctional molecules at endothelial cell-cell contacts.
(2) The local concentration and directionality of chemokines.
(3) Low-expression regions within the basement membrane or permissive exit sites.
(4) Hemodynamic shear stress and the coverage status of pericytes.
Accordingly, transendothelial migration is not a random escape event, but a directional selection process based on signal integration at the luminal surface.
6 Paracellular Migration and Transcellular Migration
6.1 Paracellular migration
Paracellular migration is the most common mode, in which leukocytes pass through junctions between adjacent endothelial cells. This process involves transient disassembly of VE-cadherin, dynamic rearrangement of junctional molecules such as PECAM-1, JAM-A, JAM-C, CD99, and ESAM, and local tension regulation by endothelial actin-myosin systems.
6.2 Transcellular migration
Transcellular migration refers to direct passage of leukocytes through the body of a single endothelial cell. This route is less common, but can become prominent under specific conditions involving blood flow, endothelial activation, and leukocyte type. It is often accompanied by endothelial membrane microdomain reorganization, formation of cup-like structures, and participation of vesicular transport systems.
6.3 Research significance of the two modes
Paracellular and transcellular migration are not mutually exclusive fixed categories. Rather, they represent two output modes jointly influenced by cell type, inflammatory environment, and vascular bed. In experimental interpretation, observations from one model should not be generalized directly to all vascular beds.
Table 1. Major Stages and Key Molecules of Leukocyte Transendothelial Migration
Stage | Main process | Key molecules |
Initial capture and rolling | Deceleration and transient adhesion | P-selectin, E-selectin, PSGL-1 |
Activation | Chemokine-triggered conversion of integrins to high-affinity states | CXCR/CCR, Rap1, talin, kindlin |
Firm adhesion | Leukocyte arrest on the endothelial surface | LFA-1, Mac-1, VLA-4; ICAM-1, VCAM-1 |
Luminal crawling | Search for transmigration sites | Mac-1, ICAM-1, cytoskeletal systems |
Endothelial crossing | Passage through junctions or the cell body | VE-cadherin, PECAM-1, JAMs, CD99 |
Basement membrane and vascular wall crossing | Entry into the interstitial space | Proteases, integrins, low-expression regions of the basement membrane |
7 Active Participation Mechanisms of Endothelial Cells
7.1 Active endothelial responses
Transendothelial migration is not a process in which leukocytes simply force the endothelium open. Upon adhesion and mechanical stimulation, endothelial cells actively initiate signal transduction, including Src family kinases, Rho GTPases, Ca2+ signaling, and myosin light chain phosphorylation, thereby remodeling junctional complexes and the cytoskeleton.
7.2 Adhesion molecule clustering and formation of signaling platforms
ICAM-1 and VCAM-1 are not merely passive ligands. After leukocyte adhesion, they cluster and form adhesion platforms enriched in ERM proteins, actin, and signaling molecules, thereby enhancing leukocyte retention, crawling, and transmigration efficiency.
7.3 Localized barrier opening
Efficient transendothelial migration does not equal global barrier breakdown. In most cases, endothelial cells permit leukocyte passage through local, transient, and reversible loosening of junctions while preserving barrier integrity in surrounding regions as much as possible. When this local control fails, overt plasma leakage and tissue edema are more likely to occur.
8 Restrictive Roles of the Basement Membrane and Pericyte Layer
8.1 Further migration after crossing the endothelium
After passing through the endothelial monolayer, leukocytes must still traverse the basement membrane and the pericyte layer. Not all basement membrane regions are equally permissive; areas with low laminin and collagen IV expression are often regarded as preferred exit sites for leukocytes.
8.2 Regulatory significance of pericytes
Pericytes can alter leukocyte extravasation efficiency by influencing basement membrane structure, endothelial stability, and the local chemotactic environment. Therefore, in microvascular studies, observation of the endothelial monolayer alone is insufficient to fully explain transvascular migration in vivo.
9 Migration Characteristics of Different Leukocyte Subsets
9.1 Neutrophils
Neutrophils are the most typical rapidly recruited cells in acute inflammation. They migrate quickly, show marked dependence on selectins and β2 integrins, and commonly enter lesions in large numbers during the early phase of acute inflammation, infection, and tissue necrosis.
9.2 Monocytes
Monocyte migration places greater emphasis on axes such as CCR2, VLA-4, and VCAM-1. After entering tissues, monocytes can further differentiate into macrophages or dendritic cells. Their significance therefore lies not only in tissue entry, but also in subsequent fate transitions.
9.3 Lymphocytes
Lymphocyte transendothelial migration shows greater tissue specificity and homeostatic surveillance characteristics. For example, in high endothelial venules, the logic governing adhesion and transmigration differs from that of inflammatory postcapillary venules.
10 Abnormal Transendothelial Migration in Disease
10.1 Acute and chronic inflammation
In infection, sepsis, and acute tissue injury, enhanced transendothelial migration supports rapid host defense. Under chronic inflammatory conditions, however, persistent leukocyte extravasation can drive tissue structural damage and progression of fibrosis.
10.2 Autoimmunity and neuroinflammation
In diseases such as multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis, abnormal leukocyte transendothelial migration is a major basis by which immune cells enter target organs and maintain local inflammation. The unique properties of the blood-brain barrier and intestinal mucosal vascular endothelium make the migration mechanisms in these disorders especially important for investigation.
10.3 Tumor microenvironment
Abnormal tumor vasculature, imbalanced adhesion molecule expression, and altered chemokine networks can simultaneously affect the entry of anti-tumor immune cells and the recruitment of pro-tumor inflammatory cells. Accordingly, transendothelial migration is not simply a matter of more being better or less being better, but of determining which leukocyte populations are recruited into the tumor microenvironment.
11 Key Readouts in Experimental Studies
11.1 Molecular-level readouts
Common indicators include changes in the expression and localization of E-selectin, P-selectin, ICAM-1, VCAM-1, PECAM-1, VE-cadherin, and JAM family molecules. On the leukocyte side, LFA-1, Mac-1, VLA-4, and the status of relevant chemokine receptors are frequently analyzed.
11.2 Dynamic behavioral readouts
Under flow conditions, rolling velocity, the number of adherent cells, crawling distance, transmigration time, and mode of transmigration provide more informative readouts than endpoint counts alone.
11.3 Functional-level readouts
Common experiments include:
(1) Transwell transendothelial migration assays.
(2) Flow chamber adhesion and rolling assays.
(3) Live-cell imaging of paracellular or transcellular migration.
(4) Endothelial permeability measurement and TEER analysis.
(5) Immunofluorescence localization analysis of endothelial junction proteins.
Table 2. Common Experimental Readouts in Leukocyte Transendothelial Migration Studies
Research level | Common indicators | Main significance |
Endothelial activation level | E-selectin, ICAM-1, VCAM-1, chemokines | Determines the recruitment-permissive state |
Leukocyte adhesion level | Rolling velocity, adhesion number, integrin activation | Determines the efficiency of early adhesion |
Transmigration level | TEM proportion, paracellular/transcellular modes | Determines transmigration efficiency and route |
Barrier level | VE-cadherin localization, permeability, TEER | Determines the degree of endothelial remodeling |
Tissue level | Inflammatory infiltration, perivascular distribution, tissue injury | Determines in vivo effects |
12 Products Related to Leukocyte Transendothelial Migration
Table 3. Product Table for Junction Remodeling and Integrin Detection Related to Leukocyte Transendothelial Migration
Catalog No. | Name | Grade and Purity | Suitable research direction/use |
Catenin Beta 1 Mouse mAb | KO Validation | Used for β-catenin detection and readout of endothelial junction remodeling | |
Recombinant Catenin Beta 1 Antibody | KO Validation | Used for β-catenin detection and validation of junction-related signaling | |
Recombinant Catenin alpha 1 Antibody | KD Validation | Used for detection of catenin α1 and study of adhesion junction complexes | |
Recombinant Human beta Catenin Protein | Carrier Free,PBS Only,≥90%(SDS-PAGE),See COA | Used for in vitro functional and binding studies of β-catenin | |
Recombinant beta Catenin Antibody | ExactAb™, Validated, Recombinant, 0.07 mg/mL | Used for β-catenin protein detection | |
Recombinant beta Catenin Antibody | Recombinant, ExactAb™, Validated, See COA | Used for β-catenin protein detection | |
Integrin alpha 4/CD49D Rat mAb | Carrier Free,Azide Free,Validated,PBS Only,≥95%(SDS-PAGE),See COA | Used for α4 integrin detection and VLA-4-dependent adhesion studies | |
Integrin alpha 4/CD49d Rat mAb | Carrier Free,ExactAb™,Low Endotoxin,Azide Free,Validated,PBS Only,≥95%(SDS-PAGE&SEC-HPLC),See COA | Used for α4 integrin detection and VLA-4-related migration studies | |
Recombinant Human Integrin alpha 4 Protein | Animal Free,Carrier Free,His Tag,≥95%(SDS-PAGE) | Used for in vitro binding and competition assays of integrin α4 | |
Integrin beta 1/CD29 Rat mAb | Carrier Free,Azide Free,Validated,PBS Only,≥95%(SDS-PAGE),See COA | Used for β1 integrin detection and study of the α4β1 adhesion axis | |
Recombinant Human Integrin beta 1 Protein | Animal Free,Carrier Free,Bioactive,ActiBioPure™,His Tag,PBS Only,≥90%(SDS-PAGE) | Used for in vitro functional studies of integrin β1 | |
Recombinant Integrin Beta 1 Antibody | KD Validation | Used for β1 integrin protein detection | |
Recombinant Integrin Beta 1 Antibody | KD Validation | Used for β1 integrin protein detection | |
Recombinant Integrin Beta 1/CD29 Antibody | KD Validation | Used for CD29/β1 integrin detection and antibody validation | |
Recombinant Integrin beta 1 Antibody | ExactAb™, Validated, Recombinant, 0.4 mg/mL | Used for β1 integrin protein detection | |
Integrin beta 7 Rat mAb | Carrier Free,Azide Free,Validated,PBS Only,≥95%(SDS-PAGE),See COA | Used for β7 integrin detection and studies related to lymphocyte tissue homing |
Table 4. Product Table for Integrin Blocking Related to Leukocyte Transendothelial Migration
Catalog No. | Name | CAS No. | Grade and Purity | Suitable research direction/use |
Abrilumab (anti-Integrin α4β7) | 1342290-43-0 | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA | Used for α4β7 integrin blockade and studies of lymphocyte transendothelial migration | |
Vedolizumab (anti-α4β7-integrin) | 943609-66-3 | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA | Used for blockade studies of α4β7-dependent adhesion and tissue homing | |
α4 integrin receptor antagonist 3 | 863226-74-8 | — | Used for α4 integrin antagonism and intervention studies of leukocyte adhesion/transendothelial migration |
The core of leukocyte transendothelial migration is not to regard it as a single-step extravasation event, but to recognize it as a staged process jointly shaped by the hemodynamic environment, leukocyte activation, endothelial responses, junctional remodeling, and basement membrane crossing.
References
[1] Wong CH, Heit B, Kubes P. Molecular regulators of leucocyte chemotaxis during inflammation. Cardiovasc Res. 2010;86(2):183-191.
[2] Lakshmikanthan S, Sobczak M, Chun C, et al. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin avß3. Blood. 2011;118(7):2015-2026.
[3] Nunes KP, Rigsby CS, Webb RC. RhoA/Rho-kinase and vascular diseases: what is the link? Cell Mol Life Sci. 2010;67(22):3823-3836.
[4] Fernandez-Borja M, van Buul JD, Hordijk PL. The regulation of leucocyte transendothelial migration by endothelial signalling events. Cardiovasc Res. 2010;86(2):202-210.
[5] Woodfin A, Voisin MB, Imhof BA, Dejana E, Engelhardt B, Nourshargh S. Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. Blood. 2009;113(24):6246-6257.
[6] Yang L, Kowalski JR, Zhan X, et al. Endothelial cell cortactin phosphorylation by Src contributes to polymorphonuclear leukocyte transmigration in vitro. Circ Res. 2006;98(3):394-402.